With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.6813-38-3,[2,2′-Bipyridine]-4,4′-dicarboxylic acid,as a common compound, the synthetic route is as follows.,6813-38-3
Thionyl chloride (300muL, 4.08mmol) was added to a suspension of 16 (400mg, 1.62mmol) in MeOH (30mL) in a dropwise fashion. The mixture was heated at reflux temperature overnight. Then, the solvent was removed under reduced pressure and the residue was partitioned between CH2Cl2 and water. The organic layer was washed with saturated aqueous NaHCO3 solution and dried over Na2SO4. Filtration, evaporation in vacuo, and recrystallization in AcOEt gave 17 (400mg, 91%): mp 200-202C; 1H NMR (CDCl3, 300MHz, delta; ppm), 8.92 (2H, d, J=4.2Hz), 8.85 (2H, s), 7.91 (2H, d, J=3.3Hz); 13C NMR (CDCl3, 75MHz, delta; ppm), 166.5, 156.0, 151.1, 140.0, 123.9, 120.0; MS (ESI) m/z 273.0 (MH+).
The synthetic route of 6813-38-3 has been constantly updated, and we look forward to future research findings.
Reference£º
Article; Miyake, Yuka; Itoh, Yukihiro; Hatanaka, Atsushi; Suzuma, Yoshinori; Suzuki, Miki; Kodama, Hidehiko; Arai, Yoshinobu; Suzuki, Takayoshi; Bioorganic and Medicinal Chemistry; vol. 27; 6; (2019); p. 1119 – 1129;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI